Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Free your minds – researchers call for change to unlock psychedelics’ potential benefit
+Print Archive
News
Free your minds – researchers call for change to unlock psychedelics’ potential benefit
Wednesday 23 October 2019, 03:30 AM

Could psilocybin from magic mushrooms be a future treatment for depression and addiction? Some researchers believe so.
Psychedelic substances such as LSD and psilocybin have been outlawed for decades, but there is growing international interest in their possible therapeutic benefits, especially in areas such as treating depression and addiction. Cliff Taylor looks at the evidence and finds local researchers keen to unlock the psychedelics’ potential
I don’t think it’s pie in the sky to prepare for the potential of using these substances in a therapeutic setting
It’s hard to believe these days
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.